Genitourinary Cancers Steering Committee Roster
The Genitourinary Cancers Steering Committee (GUSC) addresses the design, prioritization, and evaluation of concepts for phase 2, 2/3, and 3 clinical trials in genitourinary cancers. Committee activities help foster collaboration between groups and institutions engaged in conducting trials. The GUSC's membership comprises NCTN group representatives, community oncologists, Specialized Programs of Research Excellence (SPORE) representatives, biostatisticians, patient advocates, subject matter experts, and NCI staff.
Co-chairs
Jason Efstathiou, M.D., D.Phil.
Massachusetts General Hospital
Boston, MA
William Kevin Kelly, D.O.
Thomas Jefferson University
Philadelphia, PA
Daniel W. Lin M.D.
University of Washington
Seattle, WA
Members
Toni K. Choueiri, M.D.
Dana-Farber Cancer Institute
Boston, MA
Anthony Crispino
UsTOO Las Vegas
Las Vegas, NV
Elie G. Dib., M.D., M.S. FACP
St. Joseph Mercy Hospital
Ypsilanti, MI
James J. Dignam, Ph.D.
University of Chicago
Chicago, IL
Jared Foster, Ph.D.
National Cancer Institute
Bethesda, MD
Matthew D. Galsky, M.D.
The Tisch Cancer Institute at Mount Sinai
New York, NY
Naomi B. Haas, M.D.
University of Pennsylvania School of Medicine
Philadelphia, PA
Susan Halabi, Ph.D.
Duke University Medical Center
Durham, NCI
Sebastien J. Hotte, M.D., M.Sc., FRCPC
McMaster University
Hamilton, ON, Canada
Wassim Kassouf, M.D., C.M., FRCSC
McGill University
Montréal, QC, Canada
Seth P. Lerner, M.D.
Baylor College of Medicine
Houston, TX
Ravi A. Madan, M.D.
National Cancer Institute
Bethesda, MD
Bhupinder Mann, M.B.B.S.
National Cancer Institute
Bethesda, MD
David T. Marshall, M.D., M.S.
Medical University of South Carolina NCORP
Charleston, SC
Margaret Mooney, M.D., M.B.A.
National Cancer Institute
Bethesda, MD
Paul L. Nguyen, M.D.
Dana-Farber Cancer Institute
Boston, MA
Daniel P. Petrylak, M.D.
Yale University
New Haven, CT
Susan C. Poteat
Patient Advocate
Dayton, OH
Jonathan R. Rosenberg, M.D.
Memorial Sloan Kettering Cancer Center
New York, NY
Matthew J. Schipper, Ph.D., M.S.
University of Michigan
Ann Arbor, MI
Daniel E. Spratt, M.D., Ph.D.
University Hospitals of Cleveland, Cleveland Medical Center
Cleveland, OH
Robert Svatek, M.D.
University of Texas Health Science Center San Antonio
San Antonio, TX
Catherine M. Tangen, Dr.PH.
Fred Hutchinson Cancer Research Center
Seattle, WA
NCI CCCT Program Director
Abdul Tawab Amiri, Ph.D.
atawab@mail.nih.gov